*Corresponding author:Idowu Abimbola John, Department of Physiology, Lagos State University College of Medicine, 1-5 Oba Akinjobi Way GRA, Ikeja, Lagos, Nigeria
Received: September 20, 2018; Published: September 26, 2018
To view the Full Article Peer-reviewed Article PDF
Although melatonin has been shown to be involved in the aging process and as a therapeutic target during normal aging, it is yet to be widely accepted as a therapeutic target for age related vulnerabilities. With more evidences being unraveled from different studies, important lifestyle changes that will optimize its normal synthesis could be beneficial for the human population.